EUVIMEDObjevte EUVIMED
Übersichtsarbeit

Cyclodextrin based nanoparticles for smart drug delivery in colorectal cancer

Davies Marabada iD, Jinlei Li, Shijie Wei, Qing Huang, Zhizhong Wang

Chemical Biology & Drug Design · 2023

DOI: 10.1111/cbdd.14344 ↗

At a glance

Übersichtsarbeit in Chemical Biology & Drug Design, 2023. Written by Davies Marabada and 4 co-authors. Institution: School of Pharmacy, Ningxia Medical University, Yinchuan, China. Major MEDLINE topics: Cyclodextrins, Nanoparticles, Antineoplastic Agents, Colorectal Neoplasms. Cited 10 times so far (Crossref); 53 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The advancement of colorectal cancer (CRC) prevention, detection, and treatment is essential to ensure that survivors live longer and higher‐quality lives. The field of cancer detection and therapy has undergone a revolution with the development of nanotechnology for targeted drug delivery. The significant problems with the delivery of cancer drugs are their solubility, stability, and nonspecific distribution. There is a challenge that the acidic and enzymatic environment in the digestive tract will modify or destroy the medication or the active pharmaceutical ingredient. To overcome the problems, nanoparticles have been widely employed during the past several years to increase the specificity, selectivity, and controlled release of drug delivery systems. The site‐specific and targeted delivery leads to reduce toxicity and side effects. With respect to the capability and utilization of cyclodextrin‐based nanoparticles in different aspects of the tumour microenvironment and gut microbiota, a survey of current research papers was conducted via looking through databases including GoogleScholar, PubMed, Web of Science, and Scopus. This review aims to summarize cutting‐edge nanoparticulate‐based technologies and therapies for CRC.

Subjects

MeSH terms (MEDLINE)

CyclodextrinsNanoparticlesAntineoplastic AgentsColorectal NeoplasmsHumansDrug Delivery SystemsPharmaceutical PreparationsTumor Microenvironment

Author keywords

cancer therapycolorectal cancercyclodextrininclusion complexesnanoparticles

Substances

CyclodextrinsAntineoplastic AgentsPharmaceutical Preparations

Authors and institutions

  • School of Pharmacy, Ningxia Medical University, Yinchuan, China.
  • General Hospital, Ningxia Medical University, Yinchuan, China.
  • Key Laboratory of Ningxia Minority Medicine Modernization, Ministry of Education, Yinchuan, China.

ORCID profiles: Davies Marabada

Cite

APA

Marabada, D., Li, J., Wei, S., Huang, Q., & Wang, Z. (2023). Cyclodextrin based nanoparticles for smart drug delivery in colorectal cancer. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14344

Vancouver

Marabada D, Li J, Wei S, Huang Q, Wang Z. Cyclodextrin based nanoparticles for smart drug delivery in colorectal cancer. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14344

BibTeX
@article{Marabada2023,
  author = {Marabada, Davies and Li, Jinlei and Wei, Shijie and Huang, Qing and Wang, Zhizhong},
  title = {Cyclodextrin based nanoparticles for smart drug delivery in colorectal cancer},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  doi = {10.1111/cbdd.14344}
}
Start for free →